HRV-based Training Effects in Athletes

NCT04150952 | Completed DMC

• 1 other identifier: UAL-HRV
• Study Type: interventional
• Target: 14
• Locations: 1 country
• Sites: 1

Brief Summary

Monitoring individual responses to training is an important key factor to prescribe to most effective training programs. Heart-rate variability (HRV) could be used for monitoring the training status of endurance athletes in order to detect the fatigue status and to assess the adaptation to training. This direct fatigue measuring method has been little used to prescribe or regulate exercise prescription. Moreover, it allows new possibilities for the training load prescription according to an athlete's status, the response to the training load, and the adaptation to training. Regardless HRV-guided training, the athlete performance could also be influenced by precompetitive mood and anxiety, which can also be reflected in the precompetitive HRV scores and the subjective effort perception.

Conditions

Heart Rate Control; Athlete; Emotions

Keywords

Heart rate variability; Training; Endurance; Mood; Anxiety; Stress; maximal oxygen consumption

Outcome Measures

Primary Outcomes (1)

• VO2max

  Maximal oxygen consumption in treadmill test

  Change from baseline VO2max at 8 weeks

Secondary Outcomes (12)

• maximal heart rate

  Change from baseline maximal heart rate at 8 weeks

• maximal speed

  Change from baseline maximal speed at 8 weeks

• ventilatory thresolds

  Change from baseline ventilatory thresolds at 8 weeks

• respiratory quotient

  Change from baseline respiratory quotient at 8 weeks

• Time in running test

  Change from baseline time at 8 weeks

Other Outcomes (7)

• Fat mass

  Change from baseline body composition at 8 weeks

• Muscle mass

  Change from baseline body composition at 8 weeks

• Bone mass

  Change from baseline body composition at 8 weeks

Study Arms (2)

HRV-Group

EXPERIMENTAL

Athletes will train according to their basal HRV scores. If the resting HRV is higher tan their basal HRV, they will perform a high or moderate intensity training. If the resting HRV is lower, they will perform a low intensity training. If the resting HRV still lower, they will rest. They will not accumulate two or more days of high-moderate intensity training, nor two or more days of rest.

Other: HRV-based training

TRAD-Group

ACTIVE COMPARATOR

Athletes will train according to their trainer plan. Training will not be guided by their basal HRV scores.

Other: TRAD training

Interventions

HRV-based training OTHER

Intervention based on HRV-guided training for the performance improvement of athletes. Pre-competitive HRV, subjective effort perception, anxiety and mood will also be analysed.

HRV-Group

TRAD training OTHER

Traditional endurance training

TRAD-Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Belonging to the Spanish Athletics Federation.
• Training and running in Spanish Athletics Federation contest during at least two years.
• Stay in the first third of the classification of the previous season last five races.

You may not qualify if:

• Cardiovascular pathologies.
• Parameters of blood pressure (BP) outside of normality.
• Respiratory problems diagnosed.
• Be in treatment of psychological problems.
• Regular consumption of drug (s) with direct or indirect effects on the Nervous System (e.g., anxiolytics, antidepressants, neuroleptics).
• Consumption of substances not permitted by the International Athletics Federation (IAF).
• Punctual consumption of medication that could alter the performance due to suffering some disease related to cardiorespiratory system (e.g., influenza).
• Do not attend at least the 90% of the workouts during the intervention.

Sponsors & Collaborators

• Universidad de Almeria: lead

Study Sites (1)

University of Almería

Almería, 04120, Spain

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

• Alberto González Quílez, Master

  Universidad de Almeria

  STUDY CHAIR

• Antonio Granero-Gallegos, PhD

  Universidad de Almeria

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: October 24, 2019
• First Posted: November 5, 2019
• Study Start: September 7, 2019
• Primary Completion: December 7, 2019
• Study Completion: December 7, 2019
• Last Updated: May 27, 2020

Record last verified: 2020-05

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)